Metabolic Health & GLP-1 Programme

Physician-supervised metabolic optimisation programme using GLP-1 receptor agonists (semaglutide, tirzepatide), continuous glucose monitoring, and precision nutrition protocols to address weight management, insulin resistance, and metabolic dysfunction.

Helix Privé's Metabolic Health and GLP-1 Programme represents a paradigm shift in how weight and metabolic dysfunction are approached in concierge medicine. Rather than treating obesity or insulin resistance as lifestyle failures, the programme recognises these as complex neuroendocrine and metabolic conditions that respond powerfully to modern pharmacological and lifestyle interventions. The programme begins with a comprehensive metabolic assessment — fasting glucose, HbA1c, fasting insulin, HOMA-IR (insulin resistance index), full lipid panel with ApoB, liver function (including fatty liver screening via GGT and ALT), uric acid, and body composition analysis. This baseline determines the degree of metabolic dysfunction and guides the design of a personalised intervention. GLP-1 receptor agonists — including semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) — are prescribed where clinically appropriate. These medications work by mimicking the glucagon-like peptide-1 hormone, suppressing appetite, slowing gastric emptying, improving insulin sensitivity, and driving meaningful reductions in body weight and visceral fat. At Helix Privé, GLP-1 therapy is never prescribed in isolation — it is embedded within a holistic metabolic programme that includes personalised nutrition planning, resistance training guidance, sleep optimisation, and stress management. Continuous glucose monitoring (CGM) using devices such as the Freestyle Libre or Dexterity patch is integrated into the programme to provide real-time insight into glucose responses to food, exercise, and stress. CGM data is reviewed monthly with the physician to fine-tune dietary recommendations and medication dosing. The programme runs on a monthly subscription model with physician oversight, medication titration, and blood panel monitoring every 8–12 weeks. Clients typically achieve 10–20% body weight reduction and marked improvements in metabolic markers over a 6–12 month programme. The clinical team provides ongoing support via the 24/7 medical concierge channel, ensuring any side effects or questions are addressed promptly.